Poly(ethylene glycol)-sheddable reduction-sensitive polyurethane micelles for triggered intracellular drug delivery for osteosarcoma treatment

BACKGROUND: The survival rate of osteosarcoma therapy still lags behind overall cancer therapies due to the intrinsic or acquired drug resistance. Developing novel drug delivery systems that may overcome drug resistance would greatly facilitate osteosarcoma therapy. METHODS: Poly(ethylene glycol) (P...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Zhengjie, Guo, Qianping, Cai, Yan, Zhu, Xuesong, Zhu, Caihong, Li, Yuling, Li, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Speaking Orthopaedic Society 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029171/
https://www.ncbi.nlm.nih.gov/pubmed/32099805
http://dx.doi.org/10.1016/j.jot.2019.11.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029171/
https://www.ncbi.nlm.nih.gov/pubmed/32099805
http://dx.doi.org/10.1016/j.jot.2019.11.001

Ejemplares similares